3-141487100-C-T

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_006506.5(RASA2):​c.17C>T​(p.Pro6Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00523 in 1,392,716 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0034 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0055 ( 25 hom. )

Consequence

RASA2
NM_006506.5 missense

Scores

1
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7

Conservation

PhyloP100: -0.315
Variant links:
Genes affected
RASA2 (HGNC:9872): (RAS p21 protein activator 2) The protein encoded by this gene is member of the GAP1 family of GTPase-activating proteins. The gene product stimulates the GTPase activity of normal RAS p21 but not its oncogenic counterpart. Acting as a suppressor of RAS function, the protein enhances the weak intrinsic GTPase activity of RAS proteins resulting in the inactive GDP-bound form of RAS, thereby allowing control of cellular proliferation and differentiation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004214376).
BP6
Variant 3-141487100-C-T is Benign according to our data. Variant chr3-141487100-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 218684.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=5, Likely_benign=1}.
BS2
High Homozygotes in GnomAdExome4 at 25 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RASA2NM_006506.5 linkc.17C>T p.Pro6Leu missense_variant Exon 1 of 24 ENST00000286364.9 NP_006497.2 Q15283-2
RASA2NM_001303246.3 linkc.17C>T p.Pro6Leu missense_variant Exon 1 of 25 NP_001290175.1 Q15283
RASA2NM_001303245.3 linkc.17C>T p.Pro6Leu missense_variant Exon 1 of 24 NP_001290174.1 Q15283-1
RASA2XM_047448652.1 linkc.17C>T p.Pro6Leu missense_variant Exon 1 of 17 XP_047304608.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RASA2ENST00000286364.9 linkc.17C>T p.Pro6Leu missense_variant Exon 1 of 24 1 NM_006506.5 ENSP00000286364.3 Q15283-2
RASA2ENST00000515549.1 linkn.17C>T non_coding_transcript_exon_variant Exon 1 of 5 4 ENSP00000424293.1 D6RBA9

Frequencies

GnomAD3 genomes
AF:
0.00338
AC:
509
AN:
150574
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000920
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00231
Gnomad ASJ
AF:
0.000290
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.000805
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00613
Gnomad OTH
AF:
0.00290
GnomAD3 exomes
AF:
0.00357
AC:
281
AN:
78770
Hom.:
2
AF XY:
0.00317
AC XY:
141
AN XY:
44512
show subpopulations
Gnomad AFR exome
AF:
0.000897
Gnomad AMR exome
AF:
0.00250
Gnomad ASJ exome
AF:
0.000191
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00132
Gnomad FIN exome
AF:
0.000727
Gnomad NFE exome
AF:
0.00784
Gnomad OTH exome
AF:
0.00460
GnomAD4 exome
AF:
0.00545
AC:
6773
AN:
1242034
Hom.:
25
Cov.:
31
AF XY:
0.00532
AC XY:
3252
AN XY:
611394
show subpopulations
Gnomad4 AFR exome
AF:
0.000716
Gnomad4 AMR exome
AF:
0.00250
Gnomad4 ASJ exome
AF:
0.000105
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00192
Gnomad4 FIN exome
AF:
0.00101
Gnomad4 NFE exome
AF:
0.00634
Gnomad4 OTH exome
AF:
0.00503
GnomAD4 genome
AF:
0.00337
AC:
508
AN:
150682
Hom.:
1
Cov.:
32
AF XY:
0.00293
AC XY:
216
AN XY:
73610
show subpopulations
Gnomad4 AFR
AF:
0.000918
Gnomad4 AMR
AF:
0.00231
Gnomad4 ASJ
AF:
0.000290
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00124
Gnomad4 FIN
AF:
0.000805
Gnomad4 NFE
AF:
0.00613
Gnomad4 OTH
AF:
0.00287
Alfa
AF:
0.00476
Hom.:
1
Bravo
AF:
0.00322
ESP6500AA
AF:
0.000741
AC:
2
ESP6500EA
AF:
0.00223
AC:
13
ExAC
AF:
0.00152
AC:
149

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
May 15, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Aug 06, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

RASA2: BS1, BS2 -

not specified Uncertain:1Benign:2
Jun 18, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Aug 26, 2019
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: RASA2 c.17C>T (p.Pro6Leu) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0036 in 78770 control chromosomes in the gnomAD database, including 2 homozygotes. The observed variant frequency is approximately 713 fold of the estimated maximal expected allele frequency for a pathogenic variant in RASA2 causing Noonan Syndrome and Related Conditions phenotype (5e-06), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.17C>T in individuals affected with Noonan Syndrome and Related Conditions and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as benign. -

Sep 24, 2022
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

RASA2-related disorder Benign:1
Oct 26, 2020
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
20
DANN
Benign
0.97
DEOGEN2
Benign
0.25
.;T
Eigen
Benign
-0.65
Eigen_PC
Benign
-0.62
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.45
T;T
MetaRNN
Benign
0.0042
T;T
MetaSVM
Benign
-0.85
T
MutationAssessor
Benign
0.0
N;.
PrimateAI
Pathogenic
0.79
T
PROVEAN
Benign
-0.73
N;N
REVEL
Benign
0.11
Sift
Benign
0.18
T;T
Sift4G
Benign
0.24
T;T
Vest4
0.10
MVP
0.74
MPC
0.35
ClinPred
0.047
T
GERP RS
1.6
gMVP
0.35

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201352230; hg19: chr3-141205942; API